OCSE:COLO B (Denmark)
Business Description
Coloplast A/S
NAICS : 334510
Holtedam 1-3, Humlebaek, DNK, DK-3050
Compare
Compare
Traded in other countries / regions
COLO.Austria
•
COLO B.Denmark
•
CBHD.Germany
•
0QBO.Mexico
•
COLOB.Switzerland
•
0QBO.UK
•
CLPBF.USA
Description
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.21 | |||||
| Debt-to-Equity | 2.9 | |||||
| Debt-to-EBITDA | 3.01 | |||||
| Interest Coverage | 67.8 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.68 | |||||
| Beneish M-Score | -2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.6 | |||||
| 3-Year EBITDA Growth Rate | 7.5 | |||||
| 3-Year EPS without NRI Growth Rate | 7.7 | |||||
| 3-Year FCF Growth Rate | -3.6 | |||||
| 3-Year Book Growth Rate | 8.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 6.98 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 8.43 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.56 | |||||
| 9-Day RSI | 65.44 | |||||
| 14-Day RSI | 61.89 | |||||
| 6-1 Month Momentum % | -10 | |||||
| 12-1 Month Momentum % | -26.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.33 | |||||
| Quick Ratio | 0.21 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 141.28 | |||||
| Days Sales Outstanding | 57.83 | |||||
| Days Payable | 39.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.14 | |||||
| Dividend Payout Ratio | 0.85 | |||||
| 3-Year Dividend Growth Rate | 5.1 | |||||
| Forward Dividend Yield % | 2.14 | |||||
| 5-Year Yield-on-Cost % | 3.09 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.75 | |||||
| Operating Margin % | 31.92 | |||||
| Net Margin % | 23.03 | |||||
| ROE % | 66.43 | |||||
| ROA % | 24.24 | |||||
| ROIC % | 25.98 | |||||
| ROC (Joel Greenblatt) % | 86.24 | |||||
| ROCE % | 69.92 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 39.93 | |||||
| Forward PE Ratio | 31.85 | |||||
| PE Ratio without NRI | 37.72 | |||||
| Shiller PE Ratio | 50.29 | |||||
| Price-to-Owner-Earnings | 45.54 | |||||
| PEG Ratio | 5.17 | |||||
| PS Ratio | 9.19 | |||||
| PB Ratio | 25.56 | |||||
| Price-to-Free-Cash-Flow | 50.72 | |||||
| Price-to-Operating-Cash-Flow | 40.19 | |||||
| EV-to-EBIT | 33.69 | |||||
| EV-to-Forward-EBIT | 27.42 | |||||
| EV-to-EBITDA | 29.8 | |||||
| EV-to-Forward-EBITDA | 23.98 | |||||
| EV-to-Revenue | 10.15 | |||||
| EV-to-Forward-Revenue | 8.53 | |||||
| EV-to-FCF | 53.17 | |||||
| Price-to-Projected-FCF | 4.55 | |||||
| Price-to-Median-PS-Value | 1.12 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.74 | |||||
| Earnings Yield (Greenblatt) % | 2.97 | |||||
| Forward Rate of Return (Yacktman) % | 8.87 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 20,606 | ||
| EPS (TTM) (kr) | 22.26 | ||
| Beta | 0.8 | ||
| Volatility % | 27.42 | ||
| 14-Day RSI | 61.89 | ||
| 14-Day ATR (kr) | 27.379583 | ||
| 20-Day SMA (kr) | 848.61 | ||
| 12-1 Month Momentum % | -26.63 | ||
| 52-Week Range (kr) | 728.8 - 1194 | ||
| Shares Outstanding (Mil) | 212.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Coloplast A/S Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||